Clinical Trial Update: Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia [NA]

View source ↗

Summary

A clinical trial evaluating biweekly Actinomycin-D versus multi-day Methotrexate for low-risk gestational trophoblastic neoplasia; status is active but not recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choriocarcinoma
• Gestational Trophoblastic Neoplasia
• Invasive Mole

Drugs mentioned

• Actinomycin D (dactinomycin)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: xiang yang | Conditions: Gestational Trophoblastic Tumor, Gestational Trophoblastic Neoplasia | NA | Status: ACTIVE_NOT_RECRUITING